Shelf-stable mRNA delivery system targets bladder cancer cells without immune response
Published, peer-reviewed research shows a patent-pending, virus-mimicking platform technology developed at Purdue University improves upon traditional methods of targeting bladder cancer cells with messenger RNA (mRNA) therapies.
Jan 18, 2026
0
25









